Identifying and Referring Candidates for Bispecific Therapy: Key Factors in Transitioning from Community to Academic Care

Opinion
Video

Panelists discuss how patient-specific factors such as disease status, overall health, support systems, and treatment history are crucial considerations when determining readiness for potential transition to community settings for ongoing care.

Video content above is prompted by the following:

  • What patient specific factors might you consider?
  • Are there any criteria that patients need to meet to be ready to move to a community setting? Does this vary between community settings?
Recent Videos
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
The trispecific antibody JNJ-5322 demonstrated superior efficacy vs approved agents in multiple myeloma in results shared at the 2025 EHA Congress.
4 experts in this video
4 experts in this video
Related Content